Niloofar Rahmani

Array ( [id] => 8186869 [patent_doc_number] => 20120115902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => '3H-Imidazo [4, 5-B] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents' [patent_app_type] => utility [patent_app_number] => 13/119836 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24794 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115902.pdf [firstpage_image] =>[orig_patent_app_number] => 13119836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6189982 [patent_doc_number] => 20110172266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'PYRAZOLO PYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/120435 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17459 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172266.pdf [firstpage_image] =>[orig_patent_app_number] => 13120435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7711879 [patent_doc_number] => 20120004201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'PHOSPHODIESTARASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/060832 [patent_app_country] => US [patent_app_date] => 2009-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17371 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13060832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511504 [patent_doc_number] => 20110257214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'MORPHINAN COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/119905 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16355 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257214.pdf [firstpage_image] =>[orig_patent_app_number] => 13119905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6591975 [patent_doc_number] => 20100130543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'PYRAZOLE CARBOXAMIDE INHIBITORS OF FACTOR XA' [patent_app_type] => utility [patent_app_number] => 12/558906 [patent_app_country] => US [patent_app_date] => 2009-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12547 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130543.pdf [firstpage_image] =>[orig_patent_app_number] => 12558906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6189925 [patent_doc_number] => 20110172209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => '3H-IMIDAZO[4,5-B]PYRIDIN-5-OL DERIVATIVES USEFUL IN THE TREATMENT OF GPR81 RECEPTOR DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/063305 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 45139 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172209.pdf [firstpage_image] =>[orig_patent_app_number] => 13063305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8469877 [patent_doc_number] => 08299056 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => 'Aminotriazolopyridines, compositions thereof, and methods of treatment therewith' [patent_app_type] => utility [patent_app_number] => 12/555018 [patent_app_country] => US [patent_app_date] => 2009-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 192349 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12555018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657373 [patent_doc_number] => 20110306642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => '3-AZABICYCLO[3.1.0]HEXYL DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 13/061183 [patent_app_country] => US [patent_app_date] => 2009-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12739 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306642.pdf [firstpage_image] =>[orig_patent_app_number] => 13061183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6546324 [patent_doc_number] => 20100016351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'NICOTINIC ALPHA-7 RECEPTOR LIGANDS AND PREPARATION AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/551020 [patent_app_country] => US [patent_app_date] => 2009-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17265 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016351.pdf [firstpage_image] =>[orig_patent_app_number] => 12551020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320651 [patent_doc_number] => 20100113412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'IMIDAZO[1,2-a]PYRIDINES AND THEIR USE AS PHARMACEUTICALS' [patent_app_type] => utility [patent_app_number] => 12/548636 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22795 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113412.pdf [firstpage_image] =>[orig_patent_app_number] => 12548636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6190143 [patent_doc_number] => 20110172427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'PROCESS FOR PREPARING CERTAIN CINNAMIDE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/060979 [patent_app_country] => US [patent_app_date] => 2009-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13632 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172427.pdf [firstpage_image] =>[orig_patent_app_number] => 13060979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9245409 [patent_doc_number] => 08609690 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-17 [patent_title] => 'Aryl- and heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use' [patent_app_type] => utility [patent_app_number] => 13/059233 [patent_app_country] => US [patent_app_date] => 2009-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34147 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13059233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6596664 [patent_doc_number] => 20100048614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'THERAPEUTIC USES OF BICYCLIC LIGANDS OF SIGMA 2 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/543647 [patent_app_country] => US [patent_app_date] => 2009-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19348 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048614.pdf [firstpage_image] =>[orig_patent_app_number] => 12543647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9127196 [patent_doc_number] => 08575145 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-05 [patent_title] => 'Triazolopyridine compounds as PIM kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 13/059902 [patent_app_country] => US [patent_app_date] => 2009-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 52001 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13059902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8214399 [patent_doc_number] => 08193217 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'Polymorphic form of granisetron hydrochloride and methods of making the same' [patent_app_type] => utility [patent_app_number] => 12/542968 [patent_app_country] => US [patent_app_date] => 2009-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2006 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/193/08193217.pdf [firstpage_image] =>[orig_patent_app_number] => 12542968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6083980 [patent_doc_number] => 20110144100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'TRIAZOLOPYRIDINE COMPOUNDS AS PIM KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/059881 [patent_app_country] => US [patent_app_date] => 2009-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17118 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144100.pdf [firstpage_image] =>[orig_patent_app_number] => 13059881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113625 [patent_doc_number] => 20110190329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'NON-AMIDIC LINKERS WITH BRANCHED TERMINI AS CGRP RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/059361 [patent_app_country] => US [patent_app_date] => 2009-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17890 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190329.pdf [firstpage_image] =>[orig_patent_app_number] => 13059361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8398622 [patent_doc_number] => 08268994 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Fused ring heterocycle kinase modulators' [patent_app_type] => utility [patent_app_number] => 12/539077 [patent_app_country] => US [patent_app_date] => 2009-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 1 [patent_no_of_words] => 72916 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12539077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063449 [patent_doc_number] => 20110245292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => '2-HYDROXY-ETHANESULFONATE SALT' [patent_app_type] => utility [patent_app_number] => 13/058773 [patent_app_country] => US [patent_app_date] => 2009-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8287 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245292.pdf [firstpage_image] =>[orig_patent_app_number] => 13058773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8177337 [patent_doc_number] => 08178552 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-15 [patent_title] => '7-Azaindole derivatives and their use in the inhibition of c-Jun N-terminal kinase' [patent_app_type] => utility [patent_app_number] => 12/536342 [patent_app_country] => US [patent_app_date] => 2009-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 26 [patent_no_of_words] => 88856 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/178/08178552.pdf [firstpage_image] =>[orig_patent_app_number] => 12536342 [rel_patent_id] =>[rel_patent_doc_number] =>)